---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-019856"
form_type: "8-K"
ticker: "ZVSA"
cik: "0001859007"
company_name: "ZyVersa Therapeutics, Inc."
filed_at: "2025-07-16T23:59:59+00:00"
generated_at: "2026-05-18T06:18:41.627079+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# ZyVersa Therapeutics receives Nasdaq delisting notice; trading suspended July 17

## Summary
- Nasdaq Hearings Panel denied request to continue listing on the Nasdaq Capital Market.
- Common stock trading suspended at open on July 17, 2025; plans to trade on OTC Pink Limited Market.
- Delisting stems from non-compliance with minimum bid price requirement under Rule 5550(a)(2).
- Company may request review by Nasdaq Council within 15 days of Panel decision.

## SEC filing metadata
- accession: 0001641172-25-019856
- form_type: 8-K
- ticker: ZVSA
- cik: 0001859007
- company_name: ZyVersa Therapeutics, Inc.
- filed_at: 2025-07-16T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 3.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1859007/000164117225019856/0001641172-25-019856-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1859007/000164117225019856/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-019856
- JSON: https://secwatch.observer/filing/0001641172-25-019856.json
- Plain text: https://secwatch.observer/filing/0001641172-25-019856.txt

## Key facts
- Listing & Compliance Notices
  ZyVersa Therapeutics, Inc. received a nasdaq delisting notice notice regarding minimum bid price (rules 5550(a)(2)).
  - Exchange: nasdaq
  - Notice: delisting notice
  - Deficiency: minimum bid price
  - Rules: 5550(a)(2)
  source text: July 15, 2025, ZyVersa Therapeutics, Inc. (the “Company”) received a determination letter (the “Letter”) from The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Nasdaq Hearings Panel (the “Panel”) has determined to deny the Company’s request to continue its listing on The Nasdaq Capital Market. As previously disclosed, the Nasdaq Listing Qualifications Department (the “Staff”) notified the Company of its determination to delist the Company’s securities because the Company is not in compliance with the minimum bid price requirements under Listing Rule 5550(a)(2), unless the Company requ
  evidence_url: https://www.sec.gov/Archives/edgar/data/1859007/000164117225019856/0001641172-25-019856-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.